Population-level analysis of gut microbiome variation
By G. Falony, M. Joossens, Sara Vieira-Silva, Jun Wang, Youssef Darzi, Karoline Faust, A. Kurilshikov, M. Bonder, M. Valles-Colomer, D. Vandeputte and 17 more. Science, 2016
2,030 citations recorded by the source corpus.
“Normal” for the gut microbiota For the benefit of future clinical studies, it is critical to establish what constitutes a “normal” gut microbiome, if it exists at all. Through fecal samples and questionnaires, Falony et al. and Zhernakova et al. targeted general populations in Belgium and the Netherlands, respectively. Gut microbiota composition correlated with a range of factors including diet, use of medication, red blood cell counts, fecal chromogranin A, and stool consistency. The data give some hints for possible biomarkers of normal gut communities. Science, this issue pp. 560 and 565 Two large-scale studies in Western Europe establish environment-diet-microbe-host interactions. Fecal microbiome variation in the average, healthy population has remained under-investigated. Here, we analyzed two independent, extensively phenotyped cohorts: the Belgian Flemish Gut Flora Project (FGFP; discovery cohort; N = 1106) and the Dutch LifeLines-DEEP study (LLDeep; replication; N = 1135). Integration with global data sets (N combined = 3948) revealed a 14-genera core microbiota, but the 664 identified genera still underexplore total gut diversity. Sixty-nine clinical and questionnaire-based covariates were found associated to microbiota compositional variation with a 92% replication rate. Stool consistency showed the largest effect size, whereas medication explained largest total variance and interacted with other covariate-microbiota associations. Early-life events such as birth mode were not reflected in adult microbiota composition. Finally, we found that proposed disease marker genera associated to host covariates, urging inclusion of the latter in study design.
Subfields: Gastroenterology, Infectious Diseases, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/5ae66ae097acd4ef7ff9e0b5287d75e52d011fa6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Gastroenterology
In Infectious Diseases
In Molecular Biology
Citations in the corpus
- Microbiota in health and diseases (2022, background): “In a large-scale gutmicrobiota project named the Belgian Flemish Gut Flora Project, antibiotics, osmotic laxatives, hormones, benzodiazepines, antidepressants, antihistamines, and inflammatory bowel disease drugs were found to be highly relevant to the variation of gut microbiota.(90) Other studies ”
- Applications of Machine Learning in Human Microbiome Studies: A Review on Feature Selection, Biomarker Identification, Disease Prediction and Treatment (2021, methodology): “Falony et al. (2016) used biclustering to identify sample subsets with specific taxonomic signatures detecting two stable clusters showing that partially overlapped with previously described enterotypes (Falony et al., 2016).”
- Short chain fatty acids in human gut and metabolic health. (2020, neutral): “The phylogenetic core, dynamics and stability of this ecosystem have been intensively studied by high throughput 16S ribosomal RNA gene sequencing-based technologies (see recent reviews (Almeida et al. , 2019; Falony et al. , 2016; Hornung et al. , 2018; Shetty et al. , 2017).”
- The gut microbiota and inflammatory bowel disease (2014, background): “Its implication in general health as well as in a broad range of chronic diseases, including cancer, metabolic disorders, psychiatric diseases, and inflammatory disorders like IBD have been widely studied.(26,27,33-37)”
- Gut Microbiome: Profound Implications for Diet and Disease (2019, methodology): “Surprisingly, mode of birth and history of breastfeeding were not associated with one’s adult microbiota composition, and household pets only predicted a minimal fraction of microbiome variation [221].”